Bromantane Dosage: What 728 Patients Took for 28 Days (and What Happened After They Stopped)

Everyone asks the same three questions about bromantane. How much? For how long? What are the side effects?
There is one study that answers all three.
The study
28 clinics across Russia. 728 patients with asthenia: constant fatigue, weakness and poor stress tolerance. Bromantane was given under its brand name, Ladasten.
- Dose: 50 to 100 mg a day
- Length: 28 days
- Check-ups: days 3, 7, 14 and 28, then again one month after stopping
The results
- 90.8% were rated as improved on the clinical improvement scale, and 76% responded on the severity scale.
- The anti-fatigue effect showed up on day 3.
- The effect was still there one month after the last dose.
- Anxiety, low mood and sleep also improved.
Side effects
Side effects were reported in 3% of patients. Only 0.8% stopped treatment. No serious side effects were recorded.
A separate placebo-controlled trial looked for withdrawal after 28 days and did not find it. The authors read that as no addictive potential.
The honest part
The abstract of this large study reports no placebo group, so part of that 90% may be expectation. It was also done in patients with a fatigue disorder, not in healthy people.
Bromantane is not approved in the US or the EU, and athletes should know it is banned by WADA.
What people actually do
- 50 to 100 mg in the morning, the range used in the trials
- Cycles of about 4 weeks, like the studies
- Not late in the day, because it is stimulating
The source I use has 100 mg per tablet:
Bromantanerealpeptides.coView productHow it works: Bromantane tells your brain to build more dopamine.
Quick answers
What is the standard bromantane dose?
Clinical studies of bromantane (Ladasten) used 50 to 100 mg a day for 28 days.
What are the side effects of bromantane?
In a 728-patient study, side effects were reported in 3% of patients, 0.8% stopped treatment and no serious side effects were found.
Does bromantane cause withdrawal?
A placebo-controlled trial found no withdrawal syndrome after 28 days of use.
The studies
- [Treatment of asthenic disorders in patients with psychoautonomic syndrome: results of a multicenter study on efficacy and safety of ladasten]Zh Nevrol Psikhiatr Im S S Korsakova · 2010 · PMID 21322821
- [Ladasten, the new drug with psychostimulant and anxiolytic actions in treatment of neurasthenia (results of the comparative clinical study with placebo)]Zh Nevrol Psikhiatr Im S S Korsakova · 2009 · PMID 19491814
- [Pilot clinical trial of ladasten]Eksp Klin Farmakol · 2006 · PMID 16995430